The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet
Chen, Y.-H.; Yuan, L.; Chen, Y.-Y.; Qi, C.-J.
Zhonghua Nei Ke Za Zhi 47(3): 197-201
2008
ISSN/ISBN: 0578-1426 PMID: 18785501 Document Number: 615769
To observe the relationship between liver steatosis in rats with long-term high-caloric and high-fat diet and the expression of angiotensinogen (AGT), uncoupling protein 2 (UCP-2) and transforming growth factor beta1 (TGFbeta1). Then angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blocker (ARB) drugs were given to investigate whether rennin-angiotensin system (RAS) blockade can mitigate the liver steatosis and to probe its mechanisms. Forty male Wistar rats were divided into normal control group (NC group, n = 10), high-calorie and high-fat fed group (HF group, n = 10), ARB treated group (AR group, n = 10) and ACEI treated group (AE group, n = 10). Rats were fed with high-calorie and high-fat diet and given RAS inhibitor drugs (valsartan 40 mg/kg to the AR group and perindopril 4 mg/kg to the AE group) for eight weeks. Serum TG, free fatty acids (FFAs) lever and the fat content in liver were then measured with biochemical tests; insulin resistance was evaluated with euglycemic hyperinsulinemia clamp technique, the expression of UCP-2 and TGFbeta1 in liver tissue were examined with immunohistochemical staining and AGT mRNA, UCP-2 mRNA and TGFbeta1 mRNA were tested with RT-PCR. With the administration of RAS inhibitor drugs, following changes were observed. The levels of TG and FFAs and the fat content in liver decreased (P < 0.01 or P < 0.05), insulin resistance in high-fat fed rats was improved (P < 0.05), liver steatosis, inflammation and fibrosis were mitigated. The levels of UCP-2 decreased by 36.5% (P < 0.05) in AE group and 42.5% (P < 0.05) in AR group and TGFbeta1 decreased by 37% (P < 0.05) in AE group and 41.6% (P < 0.05) in AR group as compared with the HF group with immunohistochemical staining. The expression of AGTmRNA decreased by 14.9% (P < 0.05) in AE group and 21% (P < 0 .05) in AR group, UCP-2 mRNA decreased by 9% (P < 0.05) in AE group and 11% (P < 0.05) in AR group and TGFbeta1 mRNA decreased by 17% (P < 0.05) in AE group and 19% (P < 0.05) in AR group as compared with the HF group with RT-PCR. RAS blockade could improve insulin resistance, mitigate the liver injury of long term high-fat fed rats and have a protective effect on liver. The mechanism may be associated with the effects of improved insulin resistance, the interaction within RAS and the down-regulation of UCP-2 and TGFbeta1 in liver tissue.